3 results
Approved WMOCompleted
To evaluate the safety and efficacy of subcutaneousbelimumab (GSK1550188) and intravenous rituximab coadministrationin subjects with primary Sjögren*s syndrome.
Approved WMOCompleted
The primary objective of this study is to evaluate the long-term safety and tolerability of Diacerein 1% Ointment for 2 treatment cycles in subjects with EBS that were previously enrolled in studies CCP-020-301 or CCP-020-101.
Approved WMOCompleted
This research is part of the evaluation of regular care.Primary objective:(1) to investigate whether 4 weekly shockwave treatments for soldiers with mid-portion Achilles tendon endopathy result in an improvement in Achilles tendon structure after 8…